Speech-Language Pathologists in The Village, OK Accepting Medicare
2 Speech-Language Pathologists found. Showing 1 - 2
 Alexis Tompkins-carroll, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10316 Haverhill Pl, The Village, OK 73120 Phone: 405-659-1559 |
Amanda Nicole Harris, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2333 Tuscany Blvd, The Village, OK 73120 Phone: 405-286-0835 |
News Archive
No difference in TEWL between newborns bathed in water alone or with baby wash
The findings by academics at The University of Manchester, published in the Journal of Obstetric, Gynecologic and Neonatal Nursing, compared Johnson's Baby Top-to-Toe wash against plain bath water on 307 newborn babies over a four week period.
Behind the Numbers report: Employers' medical costs to increase by 9% in 2011
The nation's employers can expect medical costs to increase by 9 percent in 2011, a decrease of 0.5 percent from the 2010 growth rate, according to the annual Behind the Numbers report published today by the PricewaterhouseCoopers LLP Health Research Institute. For the first time, the majority of the American workforce is expected to have a health insurance deductible of $400 or more, as more employers return to "indemnity style" cost-sharing by raising out-of-pocket limits, replacing co-pays with co-insurance and adding high-deductible health plans.
New study of tumor genetics may help to treat patients with head and neck cancer
Head and neck tumors account for more than 40,000 new cancers annually in the United States. The most common of these is squamous cell carcinoma. Prognosis is based largely on location and size of the tumor, and if the cancer has spread, or metastasized, to lymph nodes and distant sites in the body.
X-BODY receives research grant for therapeutic project against metastatic tumor stem cells
X-BODY BioSciences, a developer of human monoclonal antibody therapeutics, today announced it has been awarded a research grant under the Patient Protection and Affordable Care Act of 2010 for its human monoclonal antibody therapeutic project targeting metastatic tumor stem cells.
What makes people susceptible to rheumatoid arthritis?
Peter K. Gregersen, MD, stares at x-rays of hands, searching out the telltale signs of inflamed joints and wrists from his research subjects with rheumatoid arthritis. With these clinical features at his side, he turns to the basic building blocks of life , the human genome , to figure out what makes these people susceptible to the disabling inflammatory condition.
› Verified 1 days ago